Xinliang Shen - Concepedia

Concepedia

Author

Xinliang Shen

National Institutes for Food and Drug Control

Also Known As

Shen, Xinliang, X.-Y Wang, Xin-Liang Shen, Xin-liang Shen, Xinliang Shen

38

Publications

1.6K

Citations

13

H-Index

24

Concepts

All Affiliations

National Institutes for Food and Drug Control National Vaccine and Serum Institute Capital Medical University Beijing Ditan Hospital Chongqing Medical University

XS

About

Xinliang Shen is an author at National Institutes for Food and Drug Control specializing in medicine, virology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.3K
2	Immunology	6	6	868
3	Microbiology	3	3	430
4	Allergy	1	1	74
5	Cell Biology	1	1	129

Xinliang Shen

×

14

Publications

1.6K

Citations

13

H-Index

	Year	Citations
A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71 Xiangxi Wang, Wei Peng, Jingshan Ren, Nature Structural & Molecular Biology Virus StructureMolecular VirologyPathogenesisSensor-adaptor MechanismVirology	2012	390
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Fengcai Zhu, Fanyue Meng, Jingxin Li, The Lancet VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirology	2013	382
Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings Dao-zhen Xu, Xuanyi Wang, Xinliang Shen, Journal of Hepatology VaccinationHepatitis DViral HepatitisImmunologyHepatitis B	2013	149
Molecular Determinants of Enterovirus 71 Viral Entry Chen Pan, Zilin Song, Yonghe Qi, Journal of Biological Chemistry Molecular VirologyPathogenesisViral PathogenesisImmunologyMolecular Determinants	2012	129
A Randomized Controlled Phase IIb Trial of Antigen-Antibody Immunogenic Complex Therapeutic Vaccine in Chronic Hepatitis B Patients Dao-zhen Xu, Kai Zhao, Limin Guo, PLoS ONE	2008	116
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial Fengcai Zhu, Zhenglun Liang, Xiuling Li, The Lancet VaccinationVaccine SafetyPlacebo-controlled Phase 2Vaccine DevelopmentImmunology	2013	87
Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines Zhenglun Liang, Qunying Mao, Qiang Gao, Vaccine VaccinationNational StandardsVaccine DevelopmentAllergyVaccine Target	2011	74
Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity Jingshan Ren, Xiangxi Wang, Ling Zhu, Journal of Virology	2015	64
Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides Xiuling Li, Chunming Mao, Shujun Ma, Biochemical and Biophysical Research Communications VaccinationSynthetic VirologyImmunologyEnterovirus 71Antiviral Response	2009	47
Comparative Analysis of the Immunogenicity and Protective Effects of Inactivated EV71 Vaccines in Mice Qunying Mao, Chenghong Dong, Xiuling Li, PLoS ONE	2012	33

Page 1